Tenders Are Invited For Pharmaceutical Products – Medicines For The Needs Of Vou A.S

Tender Detail

106520633
846202-2025
Self-Funded
Tenders Are Invited For Pharmaceutical Products – Medicines For The Needs Of Vou A.S
NCB
Europe
European Union
27-01-2026

Work Detail

Pharmaceutical Products – Medicines For The Needs Of Vou A.S. Part 1 Drugs Of Atc Group A04aa01 Ondansetron,Part 2 Drugs Of Atc Group A04aa05 Palonosetron,Part 3 Medicines Of Atc Group A04ad12 Aprepitant,Part 4 Drugs Of Atc Group B01ab04 Dalteparin,Part 5 Drugs Of Atc Group B01ab05 Enoxaparin,Part 6 Drugs Of Atc Group B01ab06 Nadroparin,Part 7 Drugs Of Atc Group H02ab02 Dexamethasone,Part 8 Drugs Of Atc Group L01aa01 Cyclophosphamide,Part 9 Medicines Of Atc Group L01aa06 Ifosfamide,Part 10 Drugs Of Atc Group L01ad01 Carmustine,Part 11 Drugs Of Atc Group L01bc02 Fluorouracil,Part 12 Drugs Of Atc Group L01bc05 Gemcitabine,Part 13 Medicines Of Atc Group L01ca04 Vinorelbine,Part 14 Drugs Of Atc Group L01cd01 Paclitaxel,Part 15 Drugs Of Atc Group L01cd02 Docetaxel,Part 16 Drugs Of Atc Group L01cd04 Cabazitaxel,Part 17 Drugs Of Atc Group L01ce01 Topotecan,Part 18 Drugs Of Atc Group L01ce02 Irinotecan,Part 19 Medicinal Products Of Atc Group L01db01 Doxorubicin,Part 20 Medicines Of Atc Group L01db03 Epirubicin,Part 21 Medicinal Products Of Atc Group L01dc01 Bleomycin,Part 22 Drugs Of Atc Group L01ex07 Cabozantinib,Part 23 Drugs Of Atc Group L01fa01 Rituximab,Part 24 Drugs Of Atc Group L01fd01 Trastuzumab,Part 25 Drugs Of Atc Group L01fd03 Trastuzumab - Emtansine,Part 26 Drugs Of Atc Group L01fd04 Trastuzumab - Deruxtecan,Part 27 Drugs Of Atc Group L01fe01 Cetuximab,Part 28 Drugs Of Atc Group L01fe02 Panitumumab,Part 29 Drugs Of Atc Group L01ff01 Nivolumab,Part 30 Drugs Of Atc Group L01ff02 Pembrolizumab,Part 31 Drugs Of Atc Group L01ff03 Durvalumab,Part 32 Drugs Of Atc Group L01ff04 Avelumab,Part 33 Medicines Of Atc Group L01ff05 Atezolizumab,Part 34 Drugs Of Atc Group L01ff06 Cemiplimab,Part 35 Drugs Of Atc Group L01fg02 Ramucirumab,Part 36 Drugs Of Atc Group L01fx05 Brentuximab - Vedotin,Part 37 Drugs Of Atc Group L01fx17 Sacituzumab -Govitecan,Part 38 Medicinal Products Of Atc Group L01xa01 Cisplatin,Part 39 Drugs Of Atc Group L01xa02 Carboplatin,Part 40 Drugs Of Atc Group L01xa03 Oxaliplatin,Part 41 Medicinal Products Of Atc Group L01xx41 Eribulin,Part 42 Drugs Of Atc Group L01xx44 Aflibercept,Part 43 Drugs Of Atc Group L01xy02 Pertuzumab And Trastuzumab,Part 44 Drugs Of Atc Group N01ab08 Sevoflurane,Part 45 Drugs Of Atc Group N01ax10 Propofol,Part 46 Drugs Of Atc Group N01bb Amides,Part 47 Drugs Of Atc Group N01bb10 Levobupivacaine,Part 48 Drugs Of Atc Group V03af Detoxification During Cytostatic Treatment - Levofolinic Acid,Part 49 Medicines Of Atc Group V03af01 Mesna,Part 50 Medicinal Products Of Atc Group V08aa01 Amidotrizoic Acid,Part 51 Drugs Of Atc Group V08ab07 Joverzol,Part 52 Drugs Of Atc Group V08ab09 Jodixanol,Part 53 Drugs Of Atc Group V08ab10 Jomeprol

Key Value

Tender Value
9,605,743 - SKK

Attachment

FileName File Description
Global Tender Document 4d3e0004-ee77-4257-b2c4-502abc970aec.html
Attachments
Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail